" class="no-js "lang="en-US"> Companies Archive - Page 134 of 145 - Medtech Alert
Monday, July 06, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 UCB | Pharmtech Focus

UCB

View Company

 Helix | Pharmtech Focus

Helix

View Company

 Bill & Melinda Gates Foundation | Pharmtech Focus

Bill & Melinda Gates Foundation

View Company

 Amyl Therapeutics | Pharmtech Focus

Amyl Therapeutics

View Company

 Viome | Pharmtech Focus

Viome

View Company

 Abbott | Pharmtech Focus

Abbott

View Company

 Pancreatic Cancer UK | Pharmtech Focus

Pancreatic Cancer UK

View Company

 Cancer Research UK | Pharmtech Focus

Cancer Research UK

View Company

 Vortex Biosciences | Pharmtech Focus

Vortex Biosciences

View Company

 Samsung Biologics | Pharmtech Focus

Samsung Biologics

Load More Results